Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06983639 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Randomized Trial Comparing Fecal Testing (FIT) to Colonoscopy for Post-polypectomy Surveillance

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Nov 1, 2025 to Jan 9, 2026
    v2
  2. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
From observational studies, it is know that the risk of developing colorectal cancer after polyp removal is lower if the patients adheres to surveillance recommendations. However, colonoscopy is burdensome for patients and colonoscopy availability is limited in many parts of the world. In addition, more than half of surveillance colonoscopies are without any findings. The trial investigates whether surveillance using fecal testing for blod is as good as colonoscopy after removal of colorectal polyps.
Trial Details
NCT Number NCT06983639
Lead Sponsor Sorlandet Hospital HF
Collaborators: Sykehuset Ostfold, University Hospital, Akershus, Vestre Viken Hospital Trust, Sykehuset Telemark Hospital Trust, Helse Møre og Romsdal HF, St. Olavs Hospital, University Hospital of North Norway, Sykehuset i Vestfold HF, Helse Stavanger HF, Turku University Hospital, Helsinki University Central Hospital, Randers Regional Hospital, Viborg Regional Hospital, Gødstrup Hospital, Horsens Hospital
Conditions
(from sponsor)
Colorectal Neoplasms
Related terms Colorectal Neoplasms, Polyps
Enrollment 4,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov